Colleen Julian
Concepts (393)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 57 | 2025 | 473 | 10.390 |
Why?
| | Pre-Eclampsia | 15 | 2025 | 204 | 4.590 |
Why?
| | Fetal Growth Retardation | 25 | 2025 | 587 | 3.920 |
Why?
| | Placenta | 13 | 2025 | 780 | 3.900 |
Why?
| | AMP-Activated Protein Kinases | 9 | 2025 | 190 | 3.410 |
Why?
| | Uterine Artery | 15 | 2024 | 75 | 2.910 |
Why?
| | Hypoxia | 27 | 2024 | 1199 | 2.790 |
Why?
| | Adaptation, Physiological | 14 | 2025 | 570 | 2.650 |
Why?
| | Fetal Hypoxia | 8 | 2024 | 56 | 2.450 |
Why?
| | Pregnancy | 63 | 2025 | 7190 | 2.380 |
Why?
| | Altitude Sickness | 15 | 2022 | 141 | 2.270 |
Why?
| | Fetal Development | 9 | 2025 | 299 | 2.040 |
Why?
| | Placental Circulation | 9 | 2025 | 70 | 1.840 |
Why?
| | Acclimatization | 13 | 2019 | 172 | 1.730 |
Why?
| | Bolivia | 19 | 2025 | 61 | 1.570 |
Why?
| | PPAR gamma | 3 | 2020 | 176 | 1.490 |
Why?
| | Oxygen | 17 | 2025 | 995 | 1.460 |
Why?
| | Birth Weight | 13 | 2024 | 522 | 1.430 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 74 | 0.930 |
Why?
| | Hypertension, Pregnancy-Induced | 5 | 2023 | 67 | 0.910 |
Why?
| | Selection, Genetic | 7 | 2019 | 256 | 0.900 |
Why?
| | Pregnancy Outcome | 4 | 2019 | 476 | 0.880 |
Why?
| | Hemodynamics | 4 | 2024 | 1121 | 0.850 |
Why?
| | Pregnancy Complications | 5 | 2017 | 592 | 0.840 |
Why?
| | Female | 79 | 2025 | 78271 | 0.830 |
Why?
| | Endothelin-1 | 2 | 2020 | 184 | 0.800 |
Why?
| | Fatty Acids | 1 | 2025 | 450 | 0.740 |
Why?
| | Biology | 1 | 2023 | 91 | 0.740 |
Why?
| | Uterus | 4 | 2020 | 226 | 0.710 |
Why?
| | Hypertension, Pulmonary | 3 | 2025 | 1980 | 0.710 |
Why?
| | Infant, Newborn | 16 | 2025 | 6429 | 0.680 |
Why?
| | Sympathetic Nervous System | 6 | 2020 | 178 | 0.630 |
Why?
| | Gestational Age | 12 | 2024 | 975 | 0.630 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 139 | 0.620 |
Why?
| | Humans | 85 | 2025 | 144759 | 0.620 |
Why?
| | Regional Blood Flow | 8 | 2024 | 514 | 0.610 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 194 | 0.590 |
Why?
| | Adult | 48 | 2025 | 40449 | 0.580 |
Why?
| | Polycythemia | 3 | 2017 | 25 | 0.580 |
Why?
| | Erythropoietin | 3 | 2017 | 100 | 0.540 |
Why?
| | Pulmonary Circulation | 2 | 2021 | 430 | 0.530 |
Why?
| | Vascular Diseases | 2 | 2017 | 251 | 0.510 |
Why?
| | Receptors, Erythropoietin | 1 | 2017 | 21 | 0.500 |
Why?
| | Signal Transduction | 5 | 2025 | 5226 | 0.500 |
Why?
| | Heart Defects, Congenital | 1 | 2025 | 914 | 0.500 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 684 | 0.480 |
Why?
| | Fetus | 5 | 2025 | 803 | 0.460 |
Why?
| | Infant, Small for Gestational Age | 3 | 2011 | 109 | 0.450 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2608 | 0.450 |
Why?
| | Case-Control Studies | 9 | 2024 | 3604 | 0.450 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2023 | 557 | 0.450 |
Why?
| | Enzymes | 2 | 2013 | 65 | 0.440 |
Why?
| | Arteries | 3 | 2022 | 259 | 0.440 |
Why?
| | Vasodilation | 4 | 2022 | 523 | 0.420 |
Why?
| | Young Adult | 20 | 2024 | 14105 | 0.400 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2021 | 675 | 0.390 |
Why?
| | DNA Methylation | 2 | 2023 | 681 | 0.350 |
Why?
| | Blood Proteins | 1 | 2013 | 249 | 0.350 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 97 | 0.350 |
Why?
| | Antioxidants | 2 | 2013 | 549 | 0.350 |
Why?
| | Vascular Resistance | 5 | 2024 | 367 | 0.350 |
Why?
| | Middle Cerebral Artery | 3 | 2024 | 56 | 0.340 |
Why?
| | Hemoglobins | 7 | 2017 | 384 | 0.340 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 85 | 0.340 |
Why?
| | Infant, Low Birth Weight | 2 | 2011 | 153 | 0.340 |
Why?
| | Oxygen Consumption | 2 | 2011 | 724 | 0.340 |
Why?
| | Erythrocytes | 4 | 2017 | 757 | 0.320 |
Why?
| | Phenotype | 3 | 2025 | 3162 | 0.310 |
Why?
| | Erythropoiesis | 2 | 2014 | 57 | 0.310 |
Why?
| | Placental Insufficiency | 2 | 2023 | 125 | 0.310 |
Why?
| | Biological Evolution | 2 | 2015 | 488 | 0.310 |
Why?
| | Oxidative Stress | 2 | 2013 | 1339 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 8 | 2019 | 2145 | 0.290 |
Why?
| | Lung Diseases | 1 | 2015 | 787 | 0.290 |
Why?
| | Women's Health | 1 | 2011 | 310 | 0.280 |
Why?
| | Cerebrovascular Circulation | 4 | 2024 | 280 | 0.280 |
Why?
| | Fertility | 1 | 2009 | 168 | 0.270 |
Why?
| | Lung | 1 | 2021 | 4109 | 0.260 |
Why?
| | Animals | 14 | 2025 | 38058 | 0.260 |
Why?
| | Hypertension | 1 | 2015 | 1263 | 0.250 |
Why?
| | Proteomics | 1 | 2013 | 1195 | 0.250 |
Why?
| | Receptor, Adenosine A2B | 2 | 2017 | 65 | 0.240 |
Why?
| | Maternal-Fetal Exchange | 2 | 2021 | 169 | 0.240 |
Why?
| | Carnitine | 1 | 2025 | 90 | 0.220 |
Why?
| | Nitric Oxide | 2 | 2020 | 897 | 0.220 |
Why?
| | Disease Models, Animal | 3 | 2021 | 4557 | 0.220 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2024 | 48 | 0.210 |
Why?
| | Male | 21 | 2025 | 72315 | 0.210 |
Why?
| | Infant Mortality | 1 | 2025 | 123 | 0.210 |
Why?
| | Placenta Growth Factor | 2 | 2022 | 26 | 0.200 |
Why?
| | HELLP Syndrome | 1 | 2023 | 5 | 0.200 |
Why?
| | Blood Pressure | 7 | 2020 | 1769 | 0.200 |
Why?
| | Physical Education and Training | 1 | 2003 | 71 | 0.200 |
Why?
| | Neonatal Screening | 1 | 2025 | 178 | 0.190 |
Why?
| | Phenylephrine | 2 | 2020 | 75 | 0.190 |
Why?
| | Europe | 5 | 2019 | 412 | 0.190 |
Why?
| | Ion Channels | 1 | 2023 | 129 | 0.190 |
Why?
| | Glucose | 2 | 2025 | 1047 | 0.190 |
Why?
| | Baroreflex | 3 | 2020 | 57 | 0.190 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5992 | 0.190 |
Why?
| | Muscle, Skeletal | 5 | 2023 | 1795 | 0.180 |
Why?
| | Amino Acids | 3 | 2023 | 521 | 0.180 |
Why?
| | Task Performance and Analysis | 1 | 2003 | 198 | 0.180 |
Why?
| | Geography | 3 | 2011 | 203 | 0.180 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2022 | 80 | 0.180 |
Why?
| | Mice | 7 | 2021 | 18339 | 0.180 |
Why?
| | Cesarean Section | 1 | 2023 | 224 | 0.180 |
Why?
| | Longitudinal Studies | 3 | 2019 | 2947 | 0.180 |
Why?
| | Acetazolamide | 2 | 2011 | 26 | 0.170 |
Why?
| | Arterial Pressure | 3 | 2020 | 136 | 0.170 |
Why?
| | Acute Disease | 3 | 2013 | 1030 | 0.170 |
Why?
| | Running | 1 | 2003 | 228 | 0.170 |
Why?
| | Postpartum Period | 1 | 2024 | 365 | 0.170 |
Why?
| | Abortion, Spontaneous | 2 | 2020 | 115 | 0.170 |
Why?
| | Phosphorylation | 3 | 2021 | 1732 | 0.170 |
Why?
| | Cardiovascular System | 2 | 2024 | 137 | 0.170 |
Why?
| | Pedigree | 2 | 2020 | 514 | 0.170 |
Why?
| | Ventricular Pressure | 1 | 2021 | 52 | 0.170 |
Why?
| | Hyperbaric Oxygenation | 1 | 2021 | 39 | 0.160 |
Why?
| | Mammals | 1 | 2022 | 293 | 0.160 |
Why?
| | Biomarkers | 4 | 2017 | 4271 | 0.160 |
Why?
| | Blood Volume | 3 | 2017 | 65 | 0.160 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5868 | 0.160 |
Why?
| | Frailty | 1 | 2023 | 198 | 0.160 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.160 |
Why?
| | Myometrium | 1 | 2020 | 38 | 0.160 |
Why?
| | Prevalence | 2 | 2025 | 2834 | 0.150 |
Why?
| | Inflammation | 1 | 2011 | 2878 | 0.150 |
Why?
| | Geographic Mapping | 1 | 2019 | 29 | 0.150 |
Why?
| | Genomics | 2 | 2023 | 834 | 0.150 |
Why?
| | Pulmonary Artery | 2 | 2015 | 1134 | 0.150 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 21 | 0.150 |
Why?
| | Thiazolidinediones | 1 | 2020 | 138 | 0.150 |
Why?
| | Dexamethasone | 2 | 2011 | 372 | 0.140 |
Why?
| | Genetics, Population | 2 | 2010 | 214 | 0.140 |
Why?
| | Nitric Oxide Synthase | 1 | 2019 | 235 | 0.140 |
Why?
| | Ventricular Function, Right | 1 | 2021 | 297 | 0.140 |
Why?
| | Gene Expression | 1 | 2023 | 1490 | 0.140 |
Why?
| | Protein Kinases | 1 | 2020 | 315 | 0.140 |
Why?
| | Adenosine | 2 | 2017 | 255 | 0.140 |
Why?
| | Peroneal Nerve | 1 | 2017 | 18 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 427 | 0.130 |
Why?
| | Puberty | 1 | 2019 | 140 | 0.130 |
Why?
| | Maternal Health Services | 1 | 2019 | 102 | 0.130 |
Why?
| | Trophoblasts | 1 | 2019 | 216 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 20 | 0.130 |
Why?
| | Time Factors | 5 | 2017 | 7173 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2025 | 1241 | 0.120 |
Why?
| | Epigenomics | 1 | 2017 | 114 | 0.120 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 628 | 0.120 |
Why?
| | Body Mass Index | 1 | 2025 | 2438 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 452 | 0.120 |
Why?
| | Heart Rate | 5 | 2020 | 855 | 0.120 |
Why?
| | Colorado | 3 | 2019 | 4564 | 0.120 |
Why?
| | Sphingosine | 1 | 2016 | 45 | 0.120 |
Why?
| | Lysophospholipids | 1 | 2016 | 77 | 0.120 |
Why?
| | Autonomic Pathways | 1 | 2015 | 2 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1716 | 0.120 |
Why?
| | Pulmonary Gas Exchange | 1 | 2015 | 119 | 0.110 |
Why?
| | California | 1 | 2017 | 475 | 0.110 |
Why?
| | Pregnancy Complications, Cardiovascular | 2 | 2024 | 83 | 0.110 |
Why?
| | Blood Glucose | 1 | 2025 | 2327 | 0.110 |
Why?
| | Double-Blind Method | 3 | 2011 | 2029 | 0.110 |
Why?
| | Pulmonary Veins | 1 | 2015 | 105 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 851 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 333 | 0.110 |
Why?
| | Receptor, Endothelin A | 1 | 2014 | 63 | 0.110 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 321 | 0.100 |
Why?
| | Aromatase | 1 | 2014 | 32 | 0.100 |
Why?
| | Ultrasonography, Prenatal | 4 | 2024 | 294 | 0.100 |
Why?
| | Biological Transport | 2 | 2019 | 417 | 0.100 |
Why?
| | Parity | 3 | 2018 | 109 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2019 | 501 | 0.100 |
Why?
| | Incidence | 2 | 2018 | 2879 | 0.100 |
Why?
| | Homeostasis | 2 | 2014 | 640 | 0.100 |
Why?
| | Tibet | 4 | 2017 | 23 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 573 | 0.090 |
Why?
| | Congenital Abnormalities | 2 | 1991 | 104 | 0.090 |
Why?
| | Ultrasonography, Doppler | 3 | 2020 | 126 | 0.090 |
Why?
| | Prospective Studies | 3 | 2022 | 7990 | 0.090 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 965 | 0.090 |
Why?
| | Delivery, Obstetric | 2 | 2011 | 160 | 0.090 |
Why?
| | Regression Analysis | 3 | 2018 | 1003 | 0.090 |
Why?
| | Body Height | 1 | 2013 | 202 | 0.090 |
Why?
| | Glycolysis | 3 | 2021 | 339 | 0.090 |
Why?
| | Healthy Volunteers | 3 | 2017 | 215 | 0.090 |
Why?
| | Prenatal Diagnosis | 2 | 1991 | 195 | 0.090 |
Why?
| | Polysomnography | 1 | 2013 | 235 | 0.090 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2011 | 14 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 594 | 0.090 |
Why?
| | Apgar Score | 1 | 2011 | 20 | 0.090 |
Why?
| | Hypoxia, Brain | 1 | 2011 | 9 | 0.090 |
Why?
| | Risk Factors | 6 | 2019 | 10779 | 0.090 |
Why?
| | Mountaineering | 1 | 2011 | 36 | 0.080 |
Why?
| | Estrogens | 1 | 2014 | 380 | 0.080 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2011 | 35 | 0.080 |
Why?
| | Brain Edema | 1 | 2011 | 62 | 0.080 |
Why?
| | Exercise | 2 | 2023 | 2201 | 0.080 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 547 | 0.080 |
Why?
| | Angiostatic Proteins | 1 | 2010 | 4 | 0.080 |
Why?
| | Lactic Acid | 2 | 2023 | 302 | 0.080 |
Why?
| | Angiogenic Proteins | 1 | 2010 | 14 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2011 | 333 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1098 | 0.080 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 576 | 0.080 |
Why?
| | Headache | 1 | 2011 | 150 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2017 | 5408 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 155 | 0.080 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 1087 | 0.080 |
Why?
| | Anthropology, Physical | 1 | 2009 | 24 | 0.080 |
Why?
| | Sheep | 2 | 2023 | 880 | 0.080 |
Why?
| | Databases, Genetic | 1 | 2010 | 248 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2022 | 17066 | 0.070 |
Why?
| | Fetal Diseases | 1 | 1991 | 191 | 0.070 |
Why?
| | Cohort Studies | 3 | 2020 | 5960 | 0.070 |
Why?
| | Adolescent | 4 | 2019 | 22428 | 0.070 |
Why?
| | Age Factors | 2 | 2019 | 3333 | 0.070 |
Why?
| | Up-Regulation | 1 | 2011 | 851 | 0.070 |
Why?
| | Fetal Blood | 1 | 2011 | 342 | 0.070 |
Why?
| | South America | 3 | 2014 | 57 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2010 | 395 | 0.070 |
Why?
| | Genome, Human | 1 | 2010 | 422 | 0.070 |
Why?
| | HIV Infections | 1 | 2023 | 3154 | 0.070 |
Why?
| | Prognosis | 1 | 2017 | 4282 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 474 | 0.070 |
Why?
| | Chronic Disease | 1 | 2013 | 1813 | 0.070 |
Why?
| | Head | 1 | 2008 | 120 | 0.060 |
Why?
| | Rest | 2 | 2019 | 124 | 0.060 |
Why?
| | Urban Health | 1 | 2007 | 96 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2016 | 32 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 49 | 0.060 |
Why?
| | Indians, South American | 3 | 2013 | 23 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 80 | 0.060 |
Why?
| | Femur | 1 | 2008 | 250 | 0.060 |
Why?
| | Health Status | 1 | 2011 | 836 | 0.060 |
Why?
| | Blood Flow Velocity | 3 | 2013 | 413 | 0.060 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2007 | 106 | 0.060 |
Why?
| | Haplotypes | 2 | 2017 | 490 | 0.060 |
Why?
| | Cold Temperature | 2 | 2017 | 209 | 0.050 |
Why?
| | Maternal Age | 2 | 2018 | 126 | 0.050 |
Why?
| | Umbilical Arteries | 1 | 2024 | 52 | 0.050 |
Why?
| | Mental Health | 1 | 2011 | 790 | 0.050 |
Why?
| | Reticulocyte Count | 1 | 2003 | 7 | 0.050 |
Why?
| | Receptors, Transferrin | 1 | 2003 | 28 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 529 | 0.050 |
Why?
| | Indians, North American | 1 | 2009 | 647 | 0.050 |
Why?
| | Down Syndrome | 1 | 1991 | 534 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1782 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 242 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 109 | 0.050 |
Why?
| | Body Weight | 1 | 2007 | 976 | 0.050 |
Why?
| | Cytokines | 1 | 2010 | 2061 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2013 | 6048 | 0.050 |
Why?
| | Serine | 1 | 2023 | 145 | 0.050 |
Why?
| | Glycine | 1 | 2023 | 187 | 0.040 |
Why?
| | Potassium Channels | 1 | 2022 | 145 | 0.040 |
Why?
| | Gene Frequency | 2 | 2014 | 481 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 55 | 0.040 |
Why?
| | Developing Countries | 1 | 2023 | 318 | 0.040 |
Why?
| | Blood Gas Analysis | 2 | 2014 | 83 | 0.040 |
Why?
| | Amniocentesis | 2 | 1991 | 20 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2020 | 12 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 10 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 2 | 2019 | 115 | 0.040 |
Why?
| | Ribonucleotides | 1 | 2020 | 26 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 498 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 68 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 128 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 3121 | 0.040 |
Why?
| | Acetylcholine | 1 | 2020 | 204 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2020 | 144 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2020 | 331 | 0.030 |
Why?
| | Accelerometry | 1 | 2019 | 119 | 0.030 |
Why?
| | Genotype | 2 | 2014 | 1833 | 0.030 |
Why?
| | Renin | 1 | 2017 | 34 | 0.030 |
Why?
| | Evoked Potentials, Motor | 1 | 2017 | 50 | 0.030 |
Why?
| | Ultrasonography | 2 | 2014 | 770 | 0.030 |
Why?
| | Arginine Vasopressin | 1 | 2017 | 44 | 0.030 |
Why?
| | Aldosterone | 1 | 2017 | 43 | 0.030 |
Why?
| | Recruitment, Neurophysiological | 1 | 2017 | 39 | 0.030 |
Why?
| | Genome-Wide Association Study | 2 | 2017 | 1406 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2017 | 167 | 0.030 |
Why?
| | Ferritins | 1 | 2017 | 69 | 0.030 |
Why?
| | Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 16 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2016 | 55 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 118 | 0.030 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 48 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 125 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 64 | 0.030 |
Why?
| | Child | 2 | 2019 | 22633 | 0.030 |
Why?
| | Posture | 1 | 2017 | 196 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 299 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 180 | 0.030 |
Why?
| | Purines | 1 | 2016 | 187 | 0.030 |
Why?
| | Arginine | 1 | 2016 | 262 | 0.030 |
Why?
| | Diastole | 1 | 2015 | 143 | 0.030 |
Why?
| | Vagus Nerve | 1 | 2015 | 91 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1539 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 766 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 375 | 0.030 |
Why?
| | Receptor, Endothelin B | 1 | 2014 | 48 | 0.030 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 50 | 0.030 |
Why?
| | Insulin | 1 | 2025 | 2507 | 0.030 |
Why?
| | Action Potentials | 1 | 2017 | 506 | 0.030 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2013 | 48 | 0.030 |
Why?
| | Evaluation Studies as Topic | 2 | 1991 | 166 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2013 | 37 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 477 | 0.020 |
Why?
| | Radial Artery | 1 | 2013 | 70 | 0.020 |
Why?
| | Infant | 2 | 2020 | 10034 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 303 | 0.020 |
Why?
| | Metabolome | 1 | 2016 | 384 | 0.020 |
Why?
| | Gonadal Steroid Hormones | 1 | 2014 | 144 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2112 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2014 | 372 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2933 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 854 | 0.020 |
Why?
| | Obstetric Labor, Premature | 1 | 1992 | 39 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2168 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 318 | 0.020 |
Why?
| | Pregnancy, High-Risk | 1 | 1991 | 14 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2011 | 31 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 449 | 0.020 |
Why?
| | Exercise Test | 1 | 2014 | 634 | 0.020 |
Why?
| | Globins | 1 | 2010 | 21 | 0.020 |
Why?
| | Live Birth | 1 | 2011 | 68 | 0.020 |
Why?
| | Iliac Artery | 1 | 2011 | 55 | 0.020 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2010 | 27 | 0.020 |
Why?
| | Aged | 2 | 2023 | 25913 | 0.020 |
Why?
| | Stillbirth | 1 | 2011 | 77 | 0.020 |
Why?
| | Pregnancy Proteins | 1 | 2010 | 35 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2010 | 78 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2010 | 206 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2010 | 183 | 0.020 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 253 | 0.020 |
Why?
| | Prenatal Care | 1 | 1992 | 307 | 0.020 |
Why?
| | Anticonvulsants | 1 | 2011 | 235 | 0.020 |
Why?
| | Intestinal Neoplasms | 1 | 1968 | 30 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2010 | 309 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2011 | 601 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 297 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1306 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1496 | 0.020 |
Why?
| | Radiotherapy | 1 | 1968 | 206 | 0.020 |
Why?
| | Insurance, Health | 1 | 1990 | 302 | 0.020 |
Why?
| | Heart Rate, Fetal | 1 | 2007 | 31 | 0.020 |
Why?
| | Models, Biological | 1 | 2015 | 1821 | 0.020 |
Why?
| | Infant, Premature | 1 | 1992 | 611 | 0.020 |
Why?
| | Biometry | 1 | 2007 | 68 | 0.020 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 72 | 0.020 |
Why?
| | Lymphoma | 1 | 1968 | 232 | 0.020 |
Why?
| | Premature Birth | 1 | 2011 | 380 | 0.020 |
Why?
| | Carcinoma | 1 | 1968 | 228 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2010 | 780 | 0.010 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1968 | 192 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 35875 | 0.010 |
Why?
| | Phylogeny | 1 | 2010 | 1016 | 0.010 |
Why?
| | Patient Selection | 1 | 1990 | 719 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1991 | 1985 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2925 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1217 | 0.010 |
Why?
| | Cognition | 1 | 2014 | 1266 | 0.010 |
Why?
| | Uterine Cervical Neoplasms | 1 | 1968 | 267 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2017 | 8265 | 0.010 |
Why?
| | Heart Failure | 1 | 2017 | 2323 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 1990 | 885 | 0.010 |
Why?
| | Lower Extremity | 1 | 2007 | 438 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2363 | 0.010 |
Why?
| | France | 2 | 1992 | 40 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3671 | 0.010 |
Why?
| | Educational Status | 2 | 1992 | 467 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 11679 | 0.010 |
Why?
| | Hospitals, Maternity | 1 | 1992 | 4 | 0.010 |
Why?
| | Fathers | 1 | 1992 | 51 | 0.010 |
Why?
| | Marriage | 1 | 1992 | 122 | 0.010 |
Why?
| | Occupations | 1 | 1990 | 51 | 0.000 |
Why?
| | Social Values | 1 | 1990 | 40 | 0.000 |
Why?
| | Chromosome Disorders | 1 | 1990 | 45 | 0.000 |
Why?
| | Religion | 1 | 1990 | 65 | 0.000 |
Why?
| | Personal Autonomy | 1 | 1990 | 57 | 0.000 |
Why?
| | Resource Allocation | 1 | 1990 | 53 | 0.000 |
Why?
| | Chromosome Aberrations | 1 | 1990 | 162 | 0.000 |
Why?
| | Culture | 1 | 1990 | 125 | 0.000 |
Why?
| | Estriol | 1 | 1968 | 6 | 0.000 |
Why?
| | Pregnancy Trimester, Second | 1 | 1989 | 82 | 0.000 |
Why?
| | Chorionic Gonadotropin | 1 | 1968 | 77 | 0.000 |
Why?
| | Social Class | 1 | 1990 | 268 | 0.000 |
Why?
| | Ileum | 1 | 1968 | 111 | 0.000 |
Why?
| | Risk | 1 | 1990 | 911 | 0.000 |
Why?
| | Smoking | 1 | 1992 | 1472 | 0.000 |
Why?
|
|
Julian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|